Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Mechanistic Models: Compartment Models in Individual and Population Analysis01:23

Mechanistic Models: Compartment Models in Individual and Population Analysis

342
Mechanistic models are utilized in individual analysis using single-source data, but imperfections arise due to data collection errors, preventing perfect prediction of observed data. The mathematical equation involves known values (Xi), observed concentrations (Ci), measurement errors (εi), model parameters (ϕj), and the related function (ƒi) for i number of values. Different least-squares metrics quantify differences between predicted and observed values. The ordinary least...
342
Dosage Regimens: Partial Pharmacokinetic Parameters01:01

Dosage Regimens: Partial Pharmacokinetic Parameters

351
It is not uncommon for complete drug pharmacokinetic profiles to remain elusive in pharmacokinetics. This necessitates certain educated assumptions by pharmacokineticists to determine appropriate dosage regimens without comprehensive pharmacokinetic data from animal or human studies. One prevalent assumption is setting the bioavailability factor, denoted as F, to 1 or 100%. This assumption caters to the scenario where a drug doesn't achieve full systemic absorption, resulting in the patient...
351
Model Approaches for Pharmacokinetic Data: Distributed Parameter Models01:06

Model Approaches for Pharmacokinetic Data: Distributed Parameter Models

319
Pharmacokinetic models are mathematical constructs that represent and predict the time course of drug concentrations in the body, providing meaningful pharmacokinetic parameters. These models are categorized into compartment, physiological, and distributed parameter models.
The distributed parameter models are specifically designed to account for variations and differences in some drug classes. This model is particularly useful for assessing regional concentrations of anticancer or...
319
Kaplan-Meier Approach01:24

Kaplan-Meier Approach

766
The Kaplan-Meier estimator is a non-parametric method used to estimate the survival function from time-to-event data. In medical research, it is frequently employed to measure the proportion of patients surviving for a certain period after treatment. This estimator is fundamental in analyzing time-to-event data, making it indispensable in clinical trials, epidemiological studies, and reliability engineering. By estimating survival probabilities, researchers can evaluate treatment effectiveness,...
766
Model Approaches for Pharmacokinetic Data: Compartment Models01:14

Model Approaches for Pharmacokinetic Data: Compartment Models

862
Compartmental analysis is a widely adopted approach to characterizing drug pharmacokinetics. It uses compartment models that conceptualize the body as a collection of reversibly communicating compartments, each representing a group of tissues exhibiting similar drug distribution characteristics. The movement rate of the drug between these compartments is typically described by first-order kinetics.
Two primary types of compartment models are recognized: mammillary and catenary. The more...
862
Methods of Documentation VI: Case Management Model01:15

Methods of Documentation VI: Case Management Model

1.1K
The case management model is a multidisciplinary approach that involves healthcare professionals from diverse disciplines, such as physicians, nurses, therapists, social workers, and pharmacists, working collaboratively to address the various needs of patients. Each healthcare professional brings unique expertise and perspectives, contributing to a more comprehensive understanding of the patient's condition and tailoring treatment plans accordingly.
For example, a patient with a chronic...
1.1K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Ethical dilemmas in the use of artificial intelligence in transfusion medicine.

Vox sanguinis·2026
Same author

Using generative artificial intelligence to standardize unstructured antigen profiles for the alloantibody exchange.

Transfusion·2026
Same author

Cost-effectiveness of primary care-based risk assessment and hereditary cancer genetic testing.

BMC primary care·2025
Same author

Comparison of 2 electronic health record data extraction methods for laboratory tests used in the Veterans Aging Cohort Study Index.

JAMIA open·2025
Same author

Long-read DNA and RNA sequencing for inherited polyposis and colorectal cancer: cryptic intronic variants and multiple mutational mechanisms.

Journal of medical genetics·2025
Same author

Imprecision medicine: Systematic gaps in reporting variants of uncertain significance (VUS) and their reclassifications.

Genetics in medicine : official journal of the American College of Medical Genetics·2025
Same journal

An automated end-to-end pipeline for the management, de-identification, and distribution of whole-slide images using DICOM: An institutional implementation.

Journal of pathology informatics·2026
Same journal

Automatic framework for PD-L1 expression evaluation in Latino patients with non-small cell lung cancer.

Journal of pathology informatics·2026
Same journal

Erratum to "Pathologists in Venice - Real world cases for an immersive training experience": Education, gaming, and show. <i>Journal of Pathology Informatics</i>, Volume 17, 2025, 100418.

Journal of pathology informatics·2026
Same journal

Erratum to PIRO: A web-based search platform for pathology reports, leveraging large language models to generate discrete searchable insights. <i>Journal of Pathology Informatics</i>, Volume 17, 2025, 100436.

Journal of pathology informatics·2026
Same journal

Erratum regarding missing Declaration of Competing Interest statements in previously published articles.

Journal of pathology informatics·2026
Same journal

An integrated AI pipeline for automated cytogenetic analysis of bone marrow karyograms in hematological malignancies: A Pix2Pix enhancement and deep learning detection approach.

Journal of pathology informatics·2026
See all related articles

Related Experiment Video

Updated: Apr 16, 2026

Author Spotlight: Developing a Point-of-Care Hemoglobin Estimation Method for Anemia Management
05:35

Author Spotlight: Developing a Point-of-Care Hemoglobin Estimation Method for Anemia Management

Published on: January 19, 2024

1.7K

A bayesian approach to laboratory utilization management.

Ronald G Hauser1, Brian R Jackson2, Brian H Shirts3

  • 1Department of Laboratory Medicine, Yale University School of Medicine, New Haven, Connecticut, USA.

Journal of Pathology Informatics
|March 17, 2015
PubMed
Summary
This summary is machine-generated.

This study introduces a novel method for laboratory utilization management, moving beyond rigid rules to objectively evaluate test orders using disease prevalence estimation. The new approach identifies patient groups with low disease risk, optimizing laboratory test ordering. Keywords: laboratory utilization management, disease prevalence, objective evaluation.

Keywords:
Delivery of health careefficiencyguideline adherencehealth careorganizationphysicians’ practice patternsprocess assessment (health care)quality assuranceutilization review

More Related Videos

Comprehensive & Cost Effective Laboratory Monitoring of HIV/AIDS: an African Role Model
23:56

Comprehensive & Cost Effective Laboratory Monitoring of HIV/AIDS: an African Role Model

Published on: October 31, 2010

17.4K
Efficient Sampling of Genetically Encoded Biosensor Design Space Enabled with a Design of Experiments and Automation Workflow
08:58

Efficient Sampling of Genetically Encoded Biosensor Design Space Enabled with a Design of Experiments and Automation Workflow

Published on: October 17, 2025

835

Related Experiment Videos

Last Updated: Apr 16, 2026

Author Spotlight: Developing a Point-of-Care Hemoglobin Estimation Method for Anemia Management
05:35

Author Spotlight: Developing a Point-of-Care Hemoglobin Estimation Method for Anemia Management

Published on: January 19, 2024

1.7K
Comprehensive & Cost Effective Laboratory Monitoring of HIV/AIDS: an African Role Model
23:56

Comprehensive & Cost Effective Laboratory Monitoring of HIV/AIDS: an African Role Model

Published on: October 31, 2010

17.4K
Efficient Sampling of Genetically Encoded Biosensor Design Space Enabled with a Design of Experiments and Automation Workflow
08:58

Efficient Sampling of Genetically Encoded Biosensor Design Space Enabled with a Design of Experiments and Automation Workflow

Published on: October 17, 2025

835

Area of Science:

  • Clinical laboratory science
  • Health services research
  • Epidemiology

Background:

  • Laboratory utilization management aims to enhance healthcare value by refining laboratory test orders.
  • Current rule-based systems for auditing lab orders are inflexible and can conflict with clinical decision-making and physician autonomy.
  • Limitations of rule-based approaches include poor adaptation to medical ambiguity and focus on order context rather than patient outcomes.

Purpose of the Study:

  • To develop and demonstrate an alternative to rule-based laboratory utilization management.
  • To introduce a novel method for objective evaluation of laboratory test requests.
  • To improve the efficiency and effectiveness of laboratory utilization audits.

Main Methods:

  • Developed a model based on an epidemiological formula relating disease prevalence, test proportion positive, sensitivity, and specificity.
  • Applied the model to estimate pretest probability (PTP) of disease in audited patient cohorts.
  • Utilized PTP comparisons across providers and patient groups for objective laboratory request evaluation, demonstrated with enterovirus (EV) meningitis testing.

Main Results:

  • The model successfully identified patient subpopulations with a low prevalence of disease.
  • These low-prevalence groups exhibited demographic and seasonal factors associated with lower risk for EV meningitis.
  • Findings suggest that laboratory test orders may be excessive for patients at low risk for EV.

Conclusions:

  • Introduced a new, objective method for auditing laboratory services within laboratory utilization management programs.
  • The proposed approach offers a more nuanced and data-driven alternative to traditional rule-based systems.
  • This method facilitates better identification of appropriate laboratory test utilization.